250 related articles for article (PubMed ID: 23982578)
41. The efficacy of botulinum toxin a injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis.
Spruijt MA; Klerkx WM; Kelder JC; Kluivers KB; Kerkhof MH
Int Urogynecol J; 2022 Nov; 33(11):2951-2961. PubMed ID: 35362767
[TBL] [Abstract][Full Text] [Related]
42. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
Gottsch HP; Yang CC; Berger RE
Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
[TBL] [Abstract][Full Text] [Related]
43. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
44. Pelvic floor myofascial pain severity and pelvic floor disorder symptom bother: is there a correlation?
Meister MR; Sutcliffe S; Badu A; Ghetti C; Lowder JL
Am J Obstet Gynecol; 2019 Sep; 221(3):235.e1-235.e15. PubMed ID: 31319079
[TBL] [Abstract][Full Text] [Related]
45. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
Nicol AL; Wu II; Ferrante FM
Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
[TBL] [Abstract][Full Text] [Related]
46. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection.
Montes-Carmona JF; Gonzalez-Perez LM; Infante-Cossio P
Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374687
[TBL] [Abstract][Full Text] [Related]
47. Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain.
Langford CF; Udvari Nagy S; Ghoniem GM
Neurourol Urodyn; 2007; 26(1):59-62. PubMed ID: 17195176
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
49. Laparoscopic Heller's myotomy or botulinum toxin injection for management of esophageal achalasia. Patient choice and treatment outcomes.
Andrews CN; Anvari M; Dobranowski J
Surg Endosc; 1999 Aug; 13(8):742-6. PubMed ID: 10430676
[TBL] [Abstract][Full Text] [Related]
50. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
[TBL] [Abstract][Full Text] [Related]
51. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
52. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
Sidebottom AJ; Patel AA; Amin J
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
[TBL] [Abstract][Full Text] [Related]
53. Botulinum toxin type A in refractory chronic migraine: an open-label trial.
Menezes C; Rodrigues B; Magalhães E; Melo A
Arq Neuropsiquiatr; 2007 Sep; 65(3A):596-8. PubMed ID: 17876397
[TBL] [Abstract][Full Text] [Related]
54. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
Desai MJ; Shkolnikova T; Nava A; Inwald D
Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
[TBL] [Abstract][Full Text] [Related]
55. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles.
Jarvis SK; Abbott JA; Lenart MB; Steensma A; Vancaillie TG
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868
[TBL] [Abstract][Full Text] [Related]
56. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
57. An update on botulinum toxin A injections of trigger points for myofascial pain.
Zhou JY; Wang D
Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
[TBL] [Abstract][Full Text] [Related]
58. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
Blumenfeld A
Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
[TBL] [Abstract][Full Text] [Related]
59. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
Guarda-Nardini L; Stecco A; Stecco C; Masiero S; Manfredini D
Cranio; 2012 Apr; 30(2):95-102. PubMed ID: 22606852
[TBL] [Abstract][Full Text] [Related]
60. Applications of botulinum toxin to the female pelvic floor: Botulinum toxin for genito-pelvic pain penetration disorder and chronic pelvic pain in women.
Karp BI; Stratton P
Toxicon; 2023 Jul; 230():107162. PubMed ID: 37201800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
